research Non-invasive method distinguishes chronic telogen effluvium from mild female pattern hair loss: clinicopathological correlation
Washing test helps identify hair loss type, low iron levels significant.
Search
for
Sort by
Research
30 / 1000+ results 
research Telogen effluvium incidence in women wearing hijab compared to non-hijab: A cross-sectional study
Wearing a hijab is linked to a higher risk of hair loss.
research Telogen Effluvium – a review of the science and current obstacles
The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.
research Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
Monocytes might be linked to hair loss after COVID-19.
research Comparison Between Hemoglobin Serum Level and Serum Ferritin level in Detecting Low Iron Store in Adult Menstruating Females with Chronic Telogen Effluvium
Serum ferritin is a better indicator than hemoglobin for detecting low iron in women with chronic hair loss.
research [Review of the post-COVID-19 syndrome associated to acute telogen effluvium].
COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.
research Telogen Effluvium: A Review
Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.
research Vitamin and Mineral Deficiencies in Patients With Telogen Effluvium: A Retrospective Cross-Sectional Study.
People with Telogen Effluvium often lack vitamin D, ferritin, and zinc.
research Race, ethnicity, and comorbidities are critical factors in the diagnosis of telogen effluvium during the COVID-19 pandemic
Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.
research Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
COVID-19 has increased hair loss, but many patients see regrowth within months.
research Telogen Effluvium
Telogen effluvium causes temporary hair loss, especially in women.
research Greater susceptibility to telogen effluvium in the setting of severe COVID-19 infection: findings from a retrospective cohort study
Severe COVID-19 increases the risk of hair loss.
research Telogen Effluvium: Exploring the Intersection of Dermatology, Psychology, and Public Health
Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.
research Evaluating the Difference Between COVID-19-Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes
COVID-19-related hair loss may have unique features compared to hair loss from other causes.
research Telogen effluvium: a 360 degree review
Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.
research Telogen effluvium and COVID-19: a cross-sectional study.
COVID-19 infection is highly related to increased hair loss, especially in women.
research Etiology, management, and outcomes of pediatric telogen effluvium: A single‐center study in the United States
Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.
research Telogen Effluvium and Trichodynia in Different Severity Groups of Post COVID-19 Patients
Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.
research ATYPICAL KAWASAKI DISEASE PRESENTING AS TELOGEN EFFLUVIUM IN AN 11 YEAR OLD FEMALE
An 11-year-old girl with Kawasaki disease experienced hair loss that improved after treatment.
research The Etiological Role of Thyroid Dysfunction and Vitamin Deficiency in Patients with Telogen Effluvium
Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.
research Clinico-Epidemiological Aspects of Telogen Effluvium In Iraqi Women
Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.
research Clinico-Epidemiological Aspects of Telogen Effluvium In Iraqi Women
Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.
research Poster 148 Severe Hair Loss during Inpatient Rehabilitation due to Telogen Effluvium: A Case Report
A woman had temporary hair loss due to stress from a spinal cord injury.
research THE ROLE OF HAIR FOLLICLE COUNTS AND RATIOS IN THE HISTOPATHOLOGICAL ASSESSMENT OF ANDROGENIC ALOPECIA, ALOPECIA AREATA AND TELOGEN EFFLUVIUM: DOES COUNTING ‘COUNT’?
Hair follicle counts and ratios are helpful in diagnosing hair loss types, but should be used with other specific features for accurate diagnosis.
research Efficacy and Safety of Omega 3 Fatty Acid in the Treatment of Telogen Effluvium in Middle Aged Women
Omega-3 fatty acids may help manage hair loss in middle-aged women.
research Foot shock stress prolongs the telogen stage of the spontaneous hair cycle in a non‐depilated mouse model
Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.
research Low‐dose oral minoxidil as treatment for non‐scarring alopecia: a systematic review
Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.
research Characteristics of the structural components of pilosebaceous follicles in the differential diagnosis of non-cicatricial alopecia
Hair follicles are thinner in alopecia patients, especially in alopecia areata.
research Trichoscopic Hallmarks in Non-cicatricial and Cicatricial Alopecia in Indian Population: A Narrative Review
Trichoscopy helps diagnose and manage different types of hair loss in the Indian population.
research Acute Versus Chronic Telogen Hair Loss: A Review of the Knowledge and Recent Facts
Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.